GATA3 and primary cutaneous T-cell non-Hodgkin lymphoma: In this study, Geng et al. used cell lines, mouse models, and histological specimens from T-cell malignancies [peripheral T-cell lymphomas—not otherwise specified (NOS), cutaneous T-cell lymphoma (CTCL), and T-cell acute lymphoblastic leukemia (T-ALL)] and provided evidence that GATA3 can induce transcriptional programs which promote T-cellular growth and proliferation [10].